Strengthening the fragile isotope supply chain
How scientists gathering in Saskatoon helped to address vulnerabilities in global isotope supply

Russia's invasion of Ukraine in 2022 exposed vulnerabilities in the global supply of isotopes, materials used in applications ranging from cancer treatment to food safety and scientific research. As two major isotope producers were disrupted, concerns grew about the resilience of a supply chain critical to healthcare and other systems around the world.
Against that backdrop, the 11th International Conference on Isotopes (ICI) convened in Saskatoon, Saskatchewan in 2023. Hosted by the Sylvia Fedoruk Canadian Centre for Nuclear Innovation (the Fedoruk Centre), the University of Saskatchewan and Discover Saskatoon, the conference brought together delegates from 21 countries to discuss isotope technologies and the future of global supply.
Turning expertise into action
ICI took place in a city with a deep stake in the issue. Saskatoon is a global centre for isotope research and production, with expertise spanning radiochemistry, accelerator physics, radiopharmaceutical development and advanced research infrastructure.
As concerns about isotope shortages mounted, conference organisers positioned Saskatoon's scientific expertise as part of the solution. Researchers, industry leaders and policymakers used the event to advance discussions on alternative production pathways, research partnerships and investment opportunities.
Within months, agreements, funding commitments and partnerships had moved from discussion to implementation. One of the most significant developments involved Actinium-225, a rare isotope used in a new generation of precision cancer treatments. During the conference, Canadian Nuclear Laboratories and the Fedoruk Centre announced a collaboration to increase production by more than 30 times, enabling larger clinical trials. By 2025, successful cyclotron irradiations and client deliveries had positioned Canada as a pivotal supplier in a constrained global market.
The conference also helped to accelerate broader efforts to strengthen and diversify isotope production. Organisations across Saskatoon's isotope ecosystem worked together to advance alternative production methods, reducing reliance on a small number of vulnerable overseas suppliers.
Research investment and collaboration
ICI helped to attract significant federal support for the sector. Prairies Economic Development Canada announced more than C$410,000 in funding for the Fedoruk Centre to advance nuclear imaging and therapeutic radiopharmaceutical research. Within five months, three new compounds had been developed and added to the centre's research portfolio.
In addition, the conference helped to strengthen the sector’s talent pipeline. Students and young professionals took part in technical tours and research competitions, connecting them directly with established experts.

A lasting impact
Hosting ICI reinforced Saskatoon's reputation as a centre for nuclear science and innovation. In doing so, it helped to attract future business events, including the 2024 Canadian Nuclear Society Annual Conference and the 2025 Canadian Association of Physicists Congress. Conference leaders also secured a successful bid for the 13th International Topical Meeting on Industrial Radiation and Radioisotope Measurement Applications (IRRMA 13), scheduled to take place in Saskatoon in 2028.
“Our intention in bringing this conference to the city was to showcase Saskatchewan as a centre of nuclear excellence with a long-standing tradition, while demonstrating our continued commitment to advancing this field and welcoming bright minds from around the world to our place and our people,” says Dr Chary Rangacharyulu, professor of physics and engineering physics at the University of Saskatchewan.
More broadly, the conference showed how a destination's intellectual capital can respond to global challenges. By bringing together scientists, industry leaders and policymakers at a critical moment, Saskatoon’s isotope community helped to strengthen isotope supply chains, accelerate research and reinforce its position as a leading hub for nuclear innovation.